InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain

January 31, 2024

https://www.globenewswire.com/news-release/2024/01/31/2821261/0/en/InterCure-Signs-Definitive-Agreement-to-Acquire-Leon-Cannabis-Pharmacy-Chain.html

NEW YORK, and HERZLIYA, Israel, Jan. 31, 2024 (GLOBE NEWSWIRE) — InterCure Ltd. (NASDAQ:INCR) (TASE: INCR) (dba Canndoc) (“InterCure” or the “Company“), the leading medical cannabis company in Israel and outside of North America, announced today that it has entered into a share purchase agreement (the “Agreement”) with the shareholders of Leon Pharm Ltd. (the “Sellers”, and “Leon Pharm”, respectively) to purchase Leon Pharm, a leading, Israel-based pharmacy chain specializing in dispensing medical cannabis in Israel, by way of a share purchase of all of the issued and outstanding share capital of Leon Pharm (the “Transaction”).  

Read more at globenewswire.com

Related news for (INCR)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.